rabbit anti human c met antibody (Santa Cruz Biotechnology)
Santa Cruz Biotechnology is a verified supplier 
94
Structured Review
Santa Cruz Biotechnology
rabbit anti human c met antibody
Rabbit Anti Human C Met Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 414 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti+human+c+met+antibody/Met+Antibody/pm41266553-131-23-28
Average 94 stars, based on 414 article reviews
Rabbit Anti Human C Met Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 414 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti+human+c+met+antibody/Met+Antibody/pm41266553-131-23-28
Average 94 stars, based on 414 article reviews
rabbit anti human c met antibody - by Bioz Stars,
2026-09
94/100 stars
Images
Related Articles
Western Blot:Article Title: MET (c-Met) protein overexpression is an emerging protein biomarker in non-small cell lung cancer Article Snippet: Masuya et al. , Rabbit polyclonal anti–c-Met (sc-10 Santa Cruz Biotechnology) , Staining intensity was classified as • Grade 0 (no staining) • Grade 1 (weak staining) • Grade 2 (moderately strong staining) • Grade 3 (very strong staining) • Grade 4 (extremely strong staining) The sample was classified as intratumoral MET positive when the intensity of MET-stained tumor cells in a given specimen was greater than grade 1. All other samples of MET-stained tumor cells were classified as intratumoral MET negative , MET expression was a significant prognostic indicator of lower survival. .. Ichimura et al. , Article Title: MET (c-Met) protein overexpression is an emerging protein biomarker in non-small cell lung cancer. Article Snippet: The final score was based on a combined assessment of membranous and cytoplasmic expression •Further evaluationwith positivity defined as having ≥50% of tumor cells positive for membranous and/or MET immunostaining with moderate or strong intensity, i.e., ≥2+ MET expression was not associated with prognosis Tachibana et al.123 Rabbit polyclonal anti-Met (IBL, Gunma, Japan) •MET low: complete absence of staining or weak to moderate staining in <40% of cancer cells •MET high: weak to moderate staining in at least 40% of tumor cells or strong staining in at least 10% of tumor cells •Weak to moderate staining was defined as staining similar to, or weaker than, the staining of normal bronchial epithelium, and strong staining was defined as staining that was clearly more intense High MET expression was significantly associated with factors indicative of poor prognosis but not with differences in survival Masuya et al.57 Rabbit polyclonal anti–c-Met (sc-10 Santa Cruz Biotechnology) Staining intensity was classified as • Grade 0 (no staining) • Grade 1 (weak staining) • Grade 2 (moderately strong staining) • Grade 3 (very strong staining) • Grade 4 (extremely strong staining) The sample was classified as intratumoral MET positive when the intensity of MET-stained tumor cells in a given specimen was greater than grade 1. .. All other samples of MET-stained tumor cells were classified as intratumoral MET negative METexpressionwasa significant prognostic indicator of lower survival Ichimura et al.11 Immunohistochemistry:Article Title: MET (c-Met) protein overexpression is an emerging protein biomarker in non-small cell lung cancer Article Snippet: Masuya et al. , Rabbit polyclonal anti–c-Met (sc-10 Santa Cruz Biotechnology) , Staining intensity was classified as • Grade 0 (no staining) • Grade 1 (weak staining) • Grade 2 (moderately strong staining) • Grade 3 (very strong staining) • Grade 4 (extremely strong staining) The sample was classified as intratumoral MET positive when the intensity of MET-stained tumor cells in a given specimen was greater than grade 1. All other samples of MET-stained tumor cells were classified as intratumoral MET negative , MET expression was a significant prognostic indicator of lower survival. .. Ichimura et al. , Article Title: MET (c-Met) protein overexpression is an emerging protein biomarker in non-small cell lung cancer. Article Snippet: The final score was based on a combined assessment of membranous and cytoplasmic expression •Further evaluationwith positivity defined as having ≥50% of tumor cells positive for membranous and/or MET immunostaining with moderate or strong intensity, i.e., ≥2+ MET expression was not associated with prognosis Tachibana et al.123 Rabbit polyclonal anti-Met (IBL, Gunma, Japan) •MET low: complete absence of staining or weak to moderate staining in <40% of cancer cells •MET high: weak to moderate staining in at least 40% of tumor cells or strong staining in at least 10% of tumor cells •Weak to moderate staining was defined as staining similar to, or weaker than, the staining of normal bronchial epithelium, and strong staining was defined as staining that was clearly more intense High MET expression was significantly associated with factors indicative of poor prognosis but not with differences in survival Masuya et al.57 Rabbit polyclonal anti–c-Met (sc-10 Santa Cruz Biotechnology) Staining intensity was classified as • Grade 0 (no staining) • Grade 1 (weak staining) • Grade 2 (moderately strong staining) • Grade 3 (very strong staining) • Grade 4 (extremely strong staining) The sample was classified as intratumoral MET positive when the intensity of MET-stained tumor cells in a given specimen was greater than grade 1. .. All other samples of MET-stained tumor cells were classified as intratumoral MET negative METexpressionwasa significant prognostic indicator of lower survival Ichimura et al.11 Expressing:Article Title: MET (c-Met) protein overexpression is an emerging protein biomarker in non-small cell lung cancer Article Snippet: Masuya et al. , Rabbit polyclonal anti–c-Met (sc-10 Santa Cruz Biotechnology) , Staining intensity was classified as • Grade 0 (no staining) • Grade 1 (weak staining) • Grade 2 (moderately strong staining) • Grade 3 (very strong staining) • Grade 4 (extremely strong staining) The sample was classified as intratumoral MET positive when the intensity of MET-stained tumor cells in a given specimen was greater than grade 1. All other samples of MET-stained tumor cells were classified as intratumoral MET negative , MET expression was a significant prognostic indicator of lower survival. .. Ichimura et al. , Article Title: MET (c-Met) protein overexpression is an emerging protein biomarker in non-small cell lung cancer. Article Snippet: The final score was based on a combined assessment of membranous and cytoplasmic expression •Further evaluationwith positivity defined as having ≥50% of tumor cells positive for membranous and/or MET immunostaining with moderate or strong intensity, i.e., ≥2+ MET expression was not associated with prognosis Tachibana et al.123 Rabbit polyclonal anti-Met (IBL, Gunma, Japan) •MET low: complete absence of staining or weak to moderate staining in <40% of cancer cells •MET high: weak to moderate staining in at least 40% of tumor cells or strong staining in at least 10% of tumor cells •Weak to moderate staining was defined as staining similar to, or weaker than, the staining of normal bronchial epithelium, and strong staining was defined as staining that was clearly more intense High MET expression was significantly associated with factors indicative of poor prognosis but not with differences in survival Masuya et al.57 Rabbit polyclonal anti–c-Met (sc-10 Santa Cruz Biotechnology) Staining intensity was classified as • Grade 0 (no staining) • Grade 1 (weak staining) • Grade 2 (moderately strong staining) • Grade 3 (very strong staining) • Grade 4 (extremely strong staining) The sample was classified as intratumoral MET positive when the intensity of MET-stained tumor cells in a given specimen was greater than grade 1. .. All other samples of MET-stained tumor cells were classified as intratumoral MET negative METexpressionwasa significant prognostic indicator of lower survival Ichimura et al.11 Over Expression:Article Title: MET (c-Met) protein overexpression is an emerging protein biomarker in non-small cell lung cancer. Article Snippet: The final score was based on a combined assessment of membranous and cytoplasmic expression •Further evaluationwith positivity defined as having ≥50% of tumor cells positive for membranous and/or MET immunostaining with moderate or strong intensity, i.e., ≥2+ MET expression was not associated with prognosis Tachibana et al.123 Rabbit polyclonal anti-Met (IBL, Gunma, Japan) •MET low: complete absence of staining or weak to moderate staining in <40% of cancer cells •MET high: weak to moderate staining in at least 40% of tumor cells or strong staining in at least 10% of tumor cells •Weak to moderate staining was defined as staining similar to, or weaker than, the staining of normal bronchial epithelium, and strong staining was defined as staining that was clearly more intense High MET expression was significantly associated with factors indicative of poor prognosis but not with differences in survival Masuya et al.57 Rabbit polyclonal anti–c-Met (sc-10 Santa Cruz Biotechnology) Staining intensity was classified as • Grade 0 (no staining) • Grade 1 (weak staining) • Grade 2 (moderately strong staining) • Grade 3 (very strong staining) • Grade 4 (extremely strong staining) The sample was classified as intratumoral MET positive when the intensity of MET-stained tumor cells in a given specimen was greater than grade 1. .. All other samples of MET-stained tumor cells were classified as intratumoral MET negative METexpressionwasa significant prognostic indicator of lower survival Ichimura et al.11 Staining:Article Title: An interaction between hepatocyte growth factor and its receptor (c-MET) prolongs the survival of chronic lymphocytic leukemic cells through STAT3 phosphorylation: a potential role of mesenchymal cells in the disease Article Snippet: 21 Immunofluorescence analysis of cell surface antigen expression on chronic lymphocytic leukemia cells Double-color fluorescence was performed by staining 10 5 CLL cells/sample at 4°C, for 30 min with FITC-labeled anti-CD19,-CD5,-CD23 and PE-labeled anti-CD19,-CD38 monoclonal antibodies (Immunotools, Friesoythe, Germany) or isotype-matched immunoglobulins. .. Aliquots of 10 5 cells were also stained with anti-human-CXCR4 monoclonal antibody (R&D system, Minneapolis, MN, USA) or, after prior permeabilization, with Flow Cytometry:Article Title: An interaction between hepatocyte growth factor and its receptor (c-MET) prolongs the survival of chronic lymphocytic leukemic cells through STAT3 phosphorylation: a potential role of mesenchymal cells in the disease Article Snippet: 21 Immunofluorescence analysis of cell surface antigen expression on chronic lymphocytic leukemia cells Double-color fluorescence was performed by staining 10 5 CLL cells/sample at 4°C, for 30 min with FITC-labeled anti-CD19,-CD5,-CD23 and PE-labeled anti-CD19,-CD38 monoclonal antibodies (Immunotools, Friesoythe, Germany) or isotype-matched immunoglobulins. .. Aliquots of 10 5 cells were also stained with anti-human-CXCR4 monoclonal antibody (R&D system, Minneapolis, MN, USA) or, after prior permeabilization, with Incubation:Article Title: Intermediate Cells in Human Prostate Epithelium Are Enriched in Proliferative Inflammatory Atrophy Article Snippet: .. After preincubation with 10% normal swine serum for 10 minutes, the slides were incubated with a dilution of 1:250 |